AWM Investment Company »

Silverback Therapeutics shares owned by AWM Investment Company

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by AWM Investment Company from 13F filings

Historical chart of AWM Investment Company investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by AWM Investment Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by AWM Investment Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.0M 100k 10.22

More positions owned by AWM Investment Company

Impinj common (PI)
ADMA Biologics common (ADMA)
American Superconductor Corpor common (AMSC)
Aspen Aerogels common (ASPN)
Destination XL Group common (DXLG)
PowerFleet common (PWFL)
Aerovironment common (AVAV)
Infusystem Holdings common (INFU)
Arbe Robotics common (ARBE)
Everspin Technology common (MRAM)
Aehr Test Systems common (AEHR)
OrthoPediatrics Corporation common (KIDS)
Natural Gas Services Group, In common (NGS)
Repligen Corporation common (RGEN)
LeMaitre Vascular common (LMAT)

View all positions for AWM Investment Company

Top funds holding Silverback Therapeutics

Deerfield Management Company
RA Capital Management
OrbiMed Advisors
Sr One Capital Management
Franklin Resources
Vanguard Group
BlackRock
K2 Principal Fund
Nextech Invest
State Street Corporation
FMR
Geode Capital Management
Perceptive Advisors
Rubric Capital Management
Royce & Associates

View all funds holding Silverback Therapeutics